Back to Search
WILLIAM LOOS, M.D.
M.D.
Internal Medicine Physician
NPI: 1417099425Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G41787(CA)
Research & Publications (20)
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.
PMID 17051369·Cancer Chemother Pharmacol·2007
8-other
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel.
PMID 17804188·J Pharm Biomed Anal·2007
8-other
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.
PMID 16574999·J Clin Oncol·2006
2-rct
Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins.
PMID 14534523·Clin Pharmacol Ther·2003
8-other
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis.
PMID 12634617·Anticancer Drugs·2003
3-trial
Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan.
PMID 11895919·Clin Cancer Res·2002
4-observational
Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel.
PMID 12187334·Anticancer Drugs·2002
8-other
Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography.
PMID 11820300·J Chromatogr B Analyt Technol Biomed Life Sci·2002
8-other
Gender-dependent pharmacokinetics of topotecan in adult patients.
PMID 11129727·Anticancer Drugs·2000
3-trial
Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography.
PMID 10778937·J Chromatogr B Biomed Sci Appl·2000
8-other
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography.
PMID 10912947·Anticancer Drugs·2000
6-review
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimens.
PMID 10914710·Clin Cancer Res·2000
4-observational
Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.
PMID 19096847·Cancer Chemother Pharmacol·2009
8-other
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
PMID 19628352·J Pharm Biomed Anal·2009
8-other
Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
PMID 18273617·Cancer Chemother Pharmacol·2008
8-other
Interaction of Cisplatin with the human organic cation transporter 2.
PMID 18559608·Clin Cancer Res·2008
3-trial
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
PMID 18204842·Cancer Chemother Pharmacol·2008
5-case
Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity.
PMID 17873515·Cancer Biol Ther·2007
5-case
The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
PMID 18055856·Oncologist·2007
6-review
Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
PMID 17766650·Oncologist·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14445 OLIVE VIEW DR, ROOM 6B119-H
SYLMAR, CA 91342 - Phone
- (818) 364-3035
Quick Facts
- NPI
- 1417099425
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile